title: Budesonide-induced periorificial dermatitis presenting as chalazion and blepharitis.
abstract: We report a case of periorificial dermatitis caused by suboptimal inhalation of budesonide for asthma. The initial skin lesions presented in the eye surroundings, leading to diagnostic difficulties and treatment of presumed chalazion and staphylococcal folliculitis. After several months, the patient developed perioral papules and pustules and was diagnosed with periorificial dermatitis. He was efficiently treated with topical metronidazole and oral erythromycin.
authors: Department of Dermatology, Odense University Hospital, Odense, Denmark. emilhenningsen@gmail.com
authors: Emil
authors: E
authors: Henningsen
authors: Anette
authors: A
authors: Bygum
mesh_terms: D018927:Anti-Asthmatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000890:Anti-Infective Agents / Q000627:therapeutic use; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy; D001762:Blepharitis / Q000175:diagnosis* / Q000209:etiology; D019819:Budesonide / Q000009:adverse effects* / Q000627:therapeutic use; D017043:Chalazion / Q000175:diagnosis* / Q000209:etiology; D003875:Drug Eruptions / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology*; D004917:Erythromycin / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008297:Male; D008397:Masks; D008795:Metronidazole / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D018927:Anti-Asthmatic Agents; D000890:Anti-Infective Agents; D008795:Metronidazole; D019819:Budesonide; D004917:Erythromycin